PD-1 or PD-L1 expression on immune cells did not have apparent impact on OS alone, but in ICS/PD-L1 subgroups analysis the PD-L1 positivity seemed to impair the survival for the ICSlow tumor patients. The gene discussed is PDCD1; the disease is neoplasm.